.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
McKesson
Healthtrust
Boehringer Ingelheim
Cipla
Fish and Richardson
US Department of Justice
Harvard Business School
Farmers Insurance

Generated: June 28, 2017

DrugPatentWatch Database Preview

FEMCON FE Drug Profile

« Back to Dashboard

Which patents cover Femcon Fe, and when can generic versions of Femcon Fe launch?

Femcon Fe is a drug marketed by Apil and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.

The generic ingredient in FEMCON FE is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

Summary for Tradename: FEMCON FE

Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Bulk Api Vendors: see list4
Clinical Trials: see list1
Patent Applications: see list2
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FEMCON FE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apil
FEMCON FE
ethinyl estradiol; norethindrone
TABLET, CHEWABLE;ORAL021490-001Nov 14, 2003ABRXYesYes6,667,050► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: FEMCON FE

Drugname Dosage Strength RLD Submissiondate
norethindrone and ethinyl estradiol and ferrous fumarateChewable Tablets0.4 mg/0.035 mgFemcon Fe4/27/2007
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Moodys
Chubb
Queensland Health
Mallinckrodt
Express Scripts
Julphar
Cipla
Teva
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot